New Delhi, Oct 3: The Hyderabad-based Dr Reddy's Laboratories has applied to the Drugs Controller General of India for permission to conduct phase-3 human clinical trials of the Russian vaccine Sputnik V against COVID-19 in India, sources said. The Indian pharma giant has collaborated with the Russian Direct Investment Fund (RDIF) to conduct clinical trials of Sputnik V as well as its distribution.

Also Read | Atal Tunnel Inauguration by PM Narendra Modi Live Streaming: Watch Live Telecast of Inauguration of Longest Highway Tunnel in the World at 10 AM Today.

Upon regulatory approval in India, RDIF will supply to drugmaker Dr Reddy's 100 million doses of the vaccine, the firm said last month. COVID-19 Vaccine Portal Launched by Union Health Ministry; Has Details About R&D, Clinical Trials of Coronavirus Vaccine; Know More About The Portal.

"The Dr Reddy's Laboratories has applied to the DCGI seeking permission to conduct phase-3 human clinical trials of the Sputnik V vaccine against COVID-19 developed by Russia. The DCGI will carry out a technical evaluation of the application before giving its approval," a source told PTI.

Also Read | India's COVID-19 Related Deaths Cross 1 Lakh Mark, Total Coronavirus Tally Rises to 64,73,545: Live Breaking News Headlines & Coronavirus Updates on October 3, 2020.

Sources said it would be multi-centre, observer-blind, randomised controlled study.

The phase-3 trial of Sputnik V is underway in Russia since September 1 on around 40,000 subjects, they added.

Sputnik V has been developed by Gamaleya National Research Centre of Epidemiology and Microbiology and RDIF.

Currently, two vaccine candidates, the indigenously developed by Bharat Biotech in collaboration with ICMR and the one developed by Zydus Cadila Ltd, are in phase 2 of human clinical trials.

The Pune-based Serum Institute of India, which has partnered with AstraZeneca for manufacturing the Oxford COVID-19 vaccine candidate, is also conducting phase 2 and 3 human clinical trials in India.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)